• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上尿路尿路上皮癌临床病理特征的预测中,上尿路细胞学和活检的临床实用性和一致性。

Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.

机构信息

Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

出版信息

Hum Pathol. 2019 Apr;86:76-84. doi: 10.1016/j.humpath.2018.11.021. Epub 2018 Dec 8.

DOI:10.1016/j.humpath.2018.11.021
PMID:30537495
Abstract

Five percent of urothelial carcinoma occurs in the upper urinary tract (UUT), a challenging location to biopsy. We aim to evaluate concordance between biopsy, cytology, and resection specimens in a large upper tract urothelial carcinoma (UTUC) cohort. One hundred seventeen UTUC resections with UUT biopsy and/or cytology specimens from 2000 to 2016 were retrieved; pathologic material was re-reviewed, evaluated for concordance, and correlated with clinical information. Fourteen percent of preoperative biopsies, including 8 from the renal pelvis and 6 from the ureter, lacked neoplastic diagnoses. Seventy-seven percent of diagnostic biopsies included subepithelial tissue; 11% demonstrated reclassification of grade and 30% demonstrated reclassification of invasion status. Twenty-six percent of renal pelvis UTUC and 36% of ureter UTUC were invasive only on resection. Of 18 UTUCs reclassified from noninvasive high-grade papillary urothelial carcinoma to invasive high-grade papillary urothelial carcinoma, 39% had prior radical cystectomy (versus 8% invasive UTUC and 11% noninvasive UTUC with concordant biopsies). Most high-grade UTUC (88%) and some low-grade UTUC (58%) resections had abnormal cytology results. Biopsy-resection pairs with concordant invasion status and pairs with discordant invasion status showed similar rates of recurrence (38% versus 38%) and metastasis (25% versus 27%). Fourteen percent of UUT biopsies lacked diagnostic neoplastic material. Grade concordance between biopsy and resection was high (89%), but 30% of cases showed invasion only on resection. Subepithelial tissue was less commonly present in ureter biopsies, particularly from the midureter or proximal ureter. UTUC in patients with prior cystectomy were more likely to show invasion on resection but not biopsy.

摘要

5%的尿路上皮癌发生在上尿路(UUT),这是一个进行活检具有挑战性的部位。我们旨在评估在一个大型上尿路尿路上皮癌(UTUC)队列中,活检、细胞学和切除标本之间的一致性。从 2000 年至 2016 年,共检索到 117 例接受 UTUC 切除手术并伴有 UUT 活检和/或细胞学标本的患者;对病理材料进行重新审查、评估一致性,并与临床信息相关联。术前活检中,包括肾盂活检 8 例和输尿管活检 6 例,有 14%未做出肿瘤性诊断。77%的诊断性活检包括上皮下组织;11%的病例分级重新分类,30%的病例侵犯状态重新分类。26%的肾盂 UTUC 和 36%的输尿管 UTUC 仅在切除时为浸润性。18 例从非浸润性高级别乳头状尿路上皮癌重新分类为浸润性高级别乳头状尿路上皮癌的 UTUC 中,39%的患者之前行根治性膀胱切除术(而浸润性 UTUC 的这一比例为 8%,与活检一致的非浸润性 UTUC 为 11%)。大多数高级别 UTUC(88%)和一些低级别 UTUC(58%)切除标本细胞学结果异常。具有一致侵犯状态的活检-切除对与具有不一致侵犯状态的活检-切除对,其复发率(38%对 38%)和转移率(25%对 27%)相似。14%的 UUT 活检缺乏诊断性肿瘤材料。活检与切除标本的分级一致性很高(89%),但 30%的病例仅在切除标本中显示侵犯。输尿管活检中上皮下组织较少见,特别是在输尿管中段或近端。既往行膀胱切除术的患者,其 UTUC 在切除标本中更可能表现为侵犯,但在活检标本中则不然。

相似文献

1
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.上尿路尿路上皮癌临床病理特征的预测中,上尿路细胞学和活检的临床实用性和一致性。
Hum Pathol. 2019 Apr;86:76-84. doi: 10.1016/j.humpath.2018.11.021. Epub 2018 Dec 8.
2
[Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].上尿路尿路上皮癌的临床病理特征及预后:368例根治性肾输尿管切除术标本分析
Zhonghua Bing Li Xue Za Zhi. 2016 Oct 8;45(10):681-686. doi: 10.3760/cma.j.issn.0529-5807.2016.10.003.
3
Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management.活检诊断上尿路尿路上皮癌的不足:对保守治疗的影响。
Urology. 2011 Jul;78(1):82-6. doi: 10.1016/j.urology.2011.02.038. Epub 2011 May 7.
4
The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.上尿路尿路上皮标本的巴黎尿液细胞学系统:与活检和手术切除的比较分析
Cytopathology. 2018 Apr;29(2):184-188. doi: 10.1111/cyt.12505. Epub 2017 Dec 18.
5
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.上尿路上皮高级别癌:尿液样本中的尿液细胞学检查和 DNA 甲基化分析比较。
Hum Pathol. 2021 Dec;118:42-48. doi: 10.1016/j.humpath.2021.09.007. Epub 2021 Sep 25.
6
Diagnosis of upper tract urothelial carcinoma-a comparative study of urinary cytology and surgical biopsy.上尿路尿路上皮癌的诊断——尿细胞学检查与手术活检的比较研究
J Am Soc Cytopathol. 2015 Jan-Feb;4(1):3-9. doi: 10.1016/j.jasc.2014.09.203. Epub 2014 Sep 8.
7
Correlation Between Confocal Laser Endomicroscopy (Cellvizio) and Histological Grading of Upper Tract Urothelial Carcinoma: A Step Forward for a Better Selection of Patients Suitable for Conservative Management.共聚焦激光显微内镜(Cellvizio)与上尿路尿路上皮癌组织学分级的相关性:为更好地选择适合保守治疗的患者迈出了一步。
Eur Urol Focus. 2018 Dec;4(6):954-959. doi: 10.1016/j.euf.2017.05.008. Epub 2017 Jun 4.
8
A Pilot Study of In Vivo Confocal Laser Endomicroscopy of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的体内共聚焦激光内镜检查的初步研究。
J Endourol. 2015 Dec;29(12):1418-23. doi: 10.1089/end.2015.0523. Epub 2015 Oct 6.
9
Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.上尿路标本的细胞学评估:采用第二代巴黎尿细胞学报告系统(附组织病理学随访)的机构回顾性研究。
Cytopathology. 2024 Mar;35(2):235-241. doi: 10.1111/cyt.13328. Epub 2023 Nov 2.
10
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.非肌层浸润性膀胱肿瘤史对上尿路尿路上皮癌患者的预后意义。
Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.

引用本文的文献

1
Clinical utility of urinary comprehensive genomic profiling in diagnosing metachronous upper tract urothelial carcinoma: a case report.尿液综合基因组分析在诊断异时性上尿路尿路上皮癌中的临床应用:一例报告
Front Urol. 2023 Aug 9;3:1229709. doi: 10.3389/fruro.2023.1229709. eCollection 2023.
2
Kidney-Sparing Surgery for Upper Tract Urothelial Carcinoma-Modalities, Outcomes, and Limitations.上尿路尿路上皮癌的保留肾手术——方式、结果及局限性
J Clin Med. 2024 Nov 2;13(21):6593. doi: 10.3390/jcm13216593.
3
Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades.
诊断上尿路尿路上皮癌:过去二十年诊断性输尿管镜检查作用及新进展综述
Asian J Urol. 2024 Apr;11(2):242-252. doi: 10.1016/j.ajur.2022.08.003. Epub 2022 Sep 23.
4
Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study.揭示 UTUC 活检和细胞学的挑战:来自全球真实实践研究的见解。
World J Urol. 2024 Mar 20;42(1):177. doi: 10.1007/s00345-024-04866-w.
5
Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract.上尿路尿路上皮癌的当代问题
Adv Anat Pathol. 2024 Mar 1;31(2):80-87. doi: 10.1097/PAP.0000000000000421. Epub 2023 Nov 27.
6
High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma.治疗前血清PD-L1水平高与上尿路尿路上皮癌的肌肉浸润及较短生存期相关。
Biomedicines. 2022 Oct 13;10(10):2560. doi: 10.3390/biomedicines10102560.